This topic contains a solution. Click here to go to the answer

Author Question: Atropine would be most useful for a victim of bioterrorism who experienced exposure to 1. ... (Read 13 times)

Charlie

  • Hero Member
  • *****
  • Posts: 640
Atropine would be most useful for a victim of bioterrorism who experienced exposure to
 
  1. ionizing radiation.
  2. nerve gas.
  3. bacterial agents.
  4. viral agents.

Question 2

Victims of a bioterrorism attack experienced initial nausea and vomiting followed by weight loss and eventual thyroid cancer. Which of the following was the most likely causative agent?
 
  1. Chemical agent
  2. Viral agent
  3. Bacterial agent
  4. Ionizing radiation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

meryzewe

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

Correct Answer: 2
Rationale: Chemicals in nerve gas cause overstimulation by the neurotransmitter acetylcholine. Atropine blocks the attachment of this neurotransmitter to receptor sites.

Answer to Question 2

Correct Answer: 4
Rationale: Exposure to radiation causes weight loss and eventual thyroid cancer.




Charlie

  • Member
  • Posts: 640
Reply 2 on: Jul 23, 2018
Wow, this really help


xthemafja

  • Member
  • Posts: 348
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library